Traders Purchase Large Volume of Amprius Technologies Put Options (NYSE:AMPX)

Amprius Technologies, Inc. (NYSE:AMPX) was the target of some unusual options trading activity on Wednesday. Stock investors bought 22,570 put options on the company. This is an increase of approximately 76% compared to the average volume of 12,835 put options.

Insider Buying and Selling at Amprius Technologies

In other Amprius Technologies news, CTO Constantin Ionel Stefan sold 492,827 shares of the firm’s stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total value of $5,933,637.08. Following the transaction, the chief technology officer directly owned 748,696 shares of the company’s stock, valued at $9,014,299.84. This trade represents a 39.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Steven Chu sold 166,632 shares of the business’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $17.92, for a total value of $2,986,045.44. Following the transaction, the director owned 127,339 shares in the company, valued at approximately $2,281,914.88. This represents a 56.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 2,929,357 shares of company stock worth $37,783,110. Insiders own 12.90% of the company’s stock.

Institutional Investors Weigh In On Amprius Technologies

A number of institutional investors have recently modified their holdings of the stock. EWA LLC grew its stake in Amprius Technologies by 3.8% in the fourth quarter. EWA LLC now owns 19,958 shares of the company’s stock worth $157,000 after purchasing an additional 723 shares in the last quarter. Victory Capital Management Inc. raised its stake in Amprius Technologies by 14.7% during the third quarter. Victory Capital Management Inc. now owns 11,817 shares of the company’s stock valued at $124,000 after buying an additional 1,516 shares in the last quarter. Graham Capital Management L.P. raised its stake in Amprius Technologies by 3.2% during the fourth quarter. Graham Capital Management L.P. now owns 49,596 shares of the company’s stock valued at $391,000 after buying an additional 1,551 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in Amprius Technologies by 5.1% during the 4th quarter. The Manufacturers Life Insurance Company now owns 33,280 shares of the company’s stock worth $263,000 after buying an additional 1,621 shares during the last quarter. Finally, First Trust Advisors LP grew its position in shares of Amprius Technologies by 6.7% in the 4th quarter. First Trust Advisors LP now owns 32,744 shares of the company’s stock worth $258,000 after acquiring an additional 2,066 shares in the last quarter. Institutional investors and hedge funds own 5.04% of the company’s stock.

Amprius Technologies Trading Down 2.5%

Amprius Technologies stock opened at $18.90 on Thursday. Amprius Technologies has a 52 week low of $1.97 and a 52 week high of $19.76. The stock has a market cap of $2.59 billion, a P/E ratio of -55.59 and a beta of 3.04. The stock has a 50 day moving average of $12.47 and a 200-day moving average of $11.34.

Amprius Technologies (NYSE:AMPX) last issued its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. The business had revenue of $25.23 million during the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. As a group, equities analysts predict that Amprius Technologies will post -0.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AMPX has been the topic of several analyst reports. Needham & Company LLC reiterated a “buy” rating and set a $20.00 target price on shares of Amprius Technologies in a report on Tuesday, March 10th. Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Roth Mkm reaffirmed a “buy” rating and issued a $20.00 price objective (up from $16.00) on shares of Amprius Technologies in a research report on Friday, March 6th. William Blair reiterated an “outperform” rating on shares of Amprius Technologies in a research note on Friday, March 6th. Finally, B. Riley Financial boosted their target price on shares of Amprius Technologies from $16.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, March 9th. Eight analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $19.75.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.